Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer

202038 citationsJournal Articlehybrid Open Access

Authors

Abrar Aljohani · University of Nottingham

Chitra Joseph · University of Nottingham

Sasagu Kurozumi · University of Nottingham

Omar J. Mohammed · University of Nottingham

Islam M. Miligy · University of Nottingham

Andrew R. Green · University of Nottingham

Emad A. Rakha ·

Abstract

This study identified MX1 as an independent predictor of poor outcome in patients with BC. Further functional studies are needed to investigate the biological role of MX1 in BC and its potential value as a therapeutic target.

Topics & Keywords

interferon and immune responses Immunotherapy and Immune Responses Virus-based gene therapy research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Breast Cancer Research and Treatment

Volume 181, Issue 3, pp. 541-551

DOI: 10.1007/s10549-020-05646-x

Field-Weighted Citation Impact: 1.79